June 2017, JSS

OncoLog - May-June 2017

6 R of remarkable response rates and long-lasting remissions are beginning to emerge from clinical trials of chimeric antigen receptor (CAR) T cells in patients with B cell malignancies. However, the promising therapy is out of reach for patients who lack sufficient T cells for CAR T cell generation or cannot afford to forgo treatment for the time it takes to generate CAR T cells. To sidestep t...

Package ‘ AICcmodavg ’ June 20 , 2017

June 20, 2017 Type Package Title Model Selection and Multimodel Inference Based on (Q)AIC(c) Version 2.1-1 Date 2017-06-19 Author Marc J. Mazerolle . Maintainer Marc J. Mazerolle Depends R (>= 3.0.0) Imports methods, stats, graphics, lattice, MASS, Matrix, nlme, stats4, survival, unmarked, VGAM, xtable Suggests betareg, coxme, fitdist...

AIDSFree Prevention Update: June 2017

U.S. President's Emergency Plan for AIDS Relief (PEPFAR) and the United States Agency for International Development (USAID) under the Cooperative Agreement Strengthening High Impact Interventions for an AIDS-free Generation (AIDSFree), number AID-OAA-A-14-00046. AIDSFree is implemented by JSI Research & Training Institute, Inc. with partners Abt Associates Inc., Elizabeth Glaser Pediatric AIDS ...

Cover vol. 14, no. 3, June 2017-

Highlights from the Current Issue: June 2017.